Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Validation of the Polish version of the EORTC QLQ‐CX24 module for the assessment of health‐related quality of life in women with cervical cancer

Validation of the Polish version of the EORTC QLQ‐CX24 module for the assessment of... The aim of our study was to undertake a prospective validation study of the Polish version of the EORTC cervical cancer (EORTC QLQ‐CX24) module used alongside the EORTC core measure. The translated module was pilot‐tested according to the established EORTC guidelines. Patients with histological confirmation of cervical cancer were eligible for the study. All patients filled out the Polish version of the EORTC QLQ‐CX24 module in addition to EORTC QLQ‐C30 and a demographic questionnaire. Standardised validity and reliability analyses were performed. One hundred and seventy‐one patients were enrolled into the study, mean age ± SD: 52.1 ± 9.6. Cronbach alpha coefficients, range 0.81–0.88, showed positive internal consistency. Re‐test was undertaken with 40 patients (23.4%). Interclass correlations for the EORTC QLQ‐CX24 ranged from 0.85 to 0.89 and proved appropriate test–retest reliability. Satisfactory convergent and discriminant validity in multi‐trait scaling analyses was seen. Concluding, the Polish version of the EORTC QLQ‐CX24 module is a reliable and valid tool for measuring HRQoL in patients with cervical cancer. It can be fully recommended for use in clinical and epidemiological settings in the Polish population. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cancer Care Wiley

Validation of the Polish version of the EORTC QLQ‐CX24 module for the assessment of health‐related quality of life in women with cervical cancer

Loading next page...
 
/lp/wiley/validation-of-the-polish-version-of-the-eortc-qlq-cx24-module-for-the-Ya5TO2jisM

References (28)

Publisher
Wiley
Copyright
Copyright © 2014 John Wiley & Sons Ltd
ISSN
0961-5423
eISSN
1365-2354
DOI
10.1111/ecc.12103
pmid
23957381
Publisher site
See Article on Publisher Site

Abstract

The aim of our study was to undertake a prospective validation study of the Polish version of the EORTC cervical cancer (EORTC QLQ‐CX24) module used alongside the EORTC core measure. The translated module was pilot‐tested according to the established EORTC guidelines. Patients with histological confirmation of cervical cancer were eligible for the study. All patients filled out the Polish version of the EORTC QLQ‐CX24 module in addition to EORTC QLQ‐C30 and a demographic questionnaire. Standardised validity and reliability analyses were performed. One hundred and seventy‐one patients were enrolled into the study, mean age ± SD: 52.1 ± 9.6. Cronbach alpha coefficients, range 0.81–0.88, showed positive internal consistency. Re‐test was undertaken with 40 patients (23.4%). Interclass correlations for the EORTC QLQ‐CX24 ranged from 0.85 to 0.89 and proved appropriate test–retest reliability. Satisfactory convergent and discriminant validity in multi‐trait scaling analyses was seen. Concluding, the Polish version of the EORTC QLQ‐CX24 module is a reliable and valid tool for measuring HRQoL in patients with cervical cancer. It can be fully recommended for use in clinical and epidemiological settings in the Polish population.

Journal

European Journal of Cancer CareWiley

Published: Jan 1, 2014

Keywords: ; ; ; ;

There are no references for this article.